Location History:
- Zürich, CH (2017 - 2019)
- Vancouver, CA (2019)
Company Filing History:
Years Active: 2017-2019
Title: Innovations of Isabella Attinger-Toller
Introduction
Isabella Attinger-Toller is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of biochemistry and molecular biology. With a total of 3 patents to her name, her work focuses on innovative solutions in protein binding and therapeutic applications.
Latest Patents
One of her latest patents is titled "Human serum albumin binding compounds and fusion proteins thereof." This invention relates to a polypeptide that binds to human serum albumin, featuring a complex amino acid sequence that allows for various modifications. Another notable patent is for "Antibody-fynomer conjugates," which describes a bi-specific fusion polypeptide that binds to interleukin-17a and interleukin-6 receptor, providing a dual-action therapeutic approach.
Career Highlights
Isabella has worked with notable companies such as Covagen AG and Mitsubishi Tanabe Pharma Corporation. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the pharmaceutical industry.
Collaborations
Isabella has collaborated with talented individuals in her field, including Dragan Grabulovski and Fabian Buller. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Isabella Attinger-Toller is a remarkable inventor whose work in protein binding and therapeutic innovations continues to impact the scientific community. Her contributions are paving the way for future advancements in biochemistry and medicine.